Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,896 | -6,899 | -44,604 | -36,582 | -26,529 |
| Depreciation Amortization | -1,245 | -569 | 959 | 701 | 491 |
| Accounts payable and accrued liabilities | -2,027 | -1,131 | 1,028 | 2,527 | -664 |
| Other Working Capital | -998 | -1,486 | 4,094 | 3,105 | 1,274 |
| Other Operating Activity | 4,256 | 2,118 | 2,423 | 157 | 2,512 |
| Operating Cash Flow | $-16,910 | $-7,967 | $-36,100 | $-30,092 | $-22,916 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -114,675 | -98,236 | 35,642 | 25,254 | 14,357 |
| Investing Cash Flow | $-114,675 | $-98,236 | $35,642 | $25,254 | $14,357 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 373 | N/A | N/A |
| Debt Repayment | -4,583 | -2,317 | -3,247 | -690 | -302 |
| Common Stock Issued | 146,130 | 108,899 | 53 | 127 | 207 |
| Other Financing Activity | 0 | 0 | 0 | -353 | 0 |
| Financing Cash Flow | $141,547 | $106,582 | $-2,821 | $-916 | $-95 |
| Beginning Cash Position | 14,394 | 14,394 | 17,673 | 17,673 | 17,673 |
| End Cash Position | 24,356 | 14,773 | 14,394 | 11,919 | 9,019 |
| Net Cash Flow | $9,962 | $379 | $-3,279 | $-5,754 | $-8,654 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,910 | -7,967 | -36,100 | -30,092 | -22,916 |
| Free Cash Flow | -16,910 | -7,967 | -36,100 | -30,092 | -22,916 |